Home > 1-Benzylpiperazine (BZP) abuse amongst attendees of the Drug Treatment Centre Board.

McNamara, SM (2009) 1-Benzylpiperazine (BZP) abuse amongst attendees of the Drug Treatment Centre Board. Irish Medical Journal, 102, (6), p. 191.

External website: http://archive.imj.ie//ViewArticleDetails.aspx?Con...

A study was commenced at the Drug Treatment Centre Board’s Drug Analysis Laboratory in order to determine the level of usage of BZP amongst attendees of the Drug Treatment Centre Board (DTCB). All of the individuals tested were methadone maintenance patients.

1-Benzylpiperazine (BZP) is a member of a group of drugs known as Piperazines. It was originally synthesized as a potential antihelminthic in farm animals, however it was found to have side effects and therefore was abandoned. In the 1970s it was investigated as a potential antidepressant, but again was abandoned when it was found to have amphetamine like effects and therefore was liable to abuse.


Item Type
Article
Publication Type
Irish-related, Open Access, Article
Drug Type
CNS stimulants
Date
2009
Page Range
p. 191
Publisher
Irish Medical Organisation
Volume
102
Number
6
EndNote
Accession Number
HRB (Available)
Related (external) link

Repository Staff Only: item control page